Skip to main content
. 2021 Sep 24;13(10):1552. doi: 10.3390/pharmaceutics13101552

Table 1.

Characterization of NLC formulations with (NLCDTX) and without DTX (NLCCTRL) in terms of size, polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency (%EE) and drug loading (%).

Formulation Size
(nm)
PDI ZP
(mV)
%EE Drug Loading (%)
NLCCTRL 222.6 ± 8.5 0.15 ± 0.04 −25.9 ± 0.2 - -
NLCDTX 214.0 ± 10.9 0.09 ± 0.01 −24.2 ± 0.3 97.3 ± 2.6 7.47 ± 0.26